Cargando…

Interdisciplinary advances reshape the delivery tools for effective NASH treatment

BACKGROUND: Nonalcoholic steatohepatitis (NASH), a severe systemic and inflammatory subtype of nonsalcoholic fatty liver disease, eventually develops into cirrhosis and hepatocellular carcinoma with few options for effective treatment. Currently potent small molecules identified in preclinical studi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Linshan, Wang, Yibing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186491/
https://www.ncbi.nlm.nih.gov/pubmed/37142161
http://dx.doi.org/10.1016/j.molmet.2023.101730
_version_ 1785042570132324352
author Chen, Linshan
Wang, Yibing
author_facet Chen, Linshan
Wang, Yibing
author_sort Chen, Linshan
collection PubMed
description BACKGROUND: Nonalcoholic steatohepatitis (NASH), a severe systemic and inflammatory subtype of nonsalcoholic fatty liver disease, eventually develops into cirrhosis and hepatocellular carcinoma with few options for effective treatment. Currently potent small molecules identified in preclinical studies are confronted with adverse effects and long-term ineffectiveness in clinical trials. Nevertheless, highly specific delivery tools designed from interdisciplinary concepts may address the significant challenges by either effectively increasing the concentrations of drugs in target cell types, or selectively manipulating the gene expression in liver to resolve NASH. SCOPE OF REVIEW: We focus on dissecting the detailed principles of the latest interdisciplinary advances and concepts that direct the design of future delivery tools to enhance the efficacy. Recent advances have indicated that cell and organelle-specific vehicles, non-coding RNA research (e.g. saRNA, hybrid miRNA) improve the specificity, while small extracellular vesicles and coacervates increase the cellular uptake of therapeutics. Moreover, strategies based on interdisciplinary advances drastically elevate drug loading capacity and delivery efficiency and ameliorate NASH and other liver diseases. MAJOR CONCLUSIONS: The latest concepts and advances in chemistry, biochemistry and machine learning technology provide the framework and strategies for the design of more effective tools to treat NASH, other pivotal liver diseases and metabolic disorders.
format Online
Article
Text
id pubmed-10186491
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-101864912023-05-17 Interdisciplinary advances reshape the delivery tools for effective NASH treatment Chen, Linshan Wang, Yibing Mol Metab Review BACKGROUND: Nonalcoholic steatohepatitis (NASH), a severe systemic and inflammatory subtype of nonsalcoholic fatty liver disease, eventually develops into cirrhosis and hepatocellular carcinoma with few options for effective treatment. Currently potent small molecules identified in preclinical studies are confronted with adverse effects and long-term ineffectiveness in clinical trials. Nevertheless, highly specific delivery tools designed from interdisciplinary concepts may address the significant challenges by either effectively increasing the concentrations of drugs in target cell types, or selectively manipulating the gene expression in liver to resolve NASH. SCOPE OF REVIEW: We focus on dissecting the detailed principles of the latest interdisciplinary advances and concepts that direct the design of future delivery tools to enhance the efficacy. Recent advances have indicated that cell and organelle-specific vehicles, non-coding RNA research (e.g. saRNA, hybrid miRNA) improve the specificity, while small extracellular vesicles and coacervates increase the cellular uptake of therapeutics. Moreover, strategies based on interdisciplinary advances drastically elevate drug loading capacity and delivery efficiency and ameliorate NASH and other liver diseases. MAJOR CONCLUSIONS: The latest concepts and advances in chemistry, biochemistry and machine learning technology provide the framework and strategies for the design of more effective tools to treat NASH, other pivotal liver diseases and metabolic disorders. Elsevier 2023-05-02 /pmc/articles/PMC10186491/ /pubmed/37142161 http://dx.doi.org/10.1016/j.molmet.2023.101730 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Review
Chen, Linshan
Wang, Yibing
Interdisciplinary advances reshape the delivery tools for effective NASH treatment
title Interdisciplinary advances reshape the delivery tools for effective NASH treatment
title_full Interdisciplinary advances reshape the delivery tools for effective NASH treatment
title_fullStr Interdisciplinary advances reshape the delivery tools for effective NASH treatment
title_full_unstemmed Interdisciplinary advances reshape the delivery tools for effective NASH treatment
title_short Interdisciplinary advances reshape the delivery tools for effective NASH treatment
title_sort interdisciplinary advances reshape the delivery tools for effective nash treatment
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186491/
https://www.ncbi.nlm.nih.gov/pubmed/37142161
http://dx.doi.org/10.1016/j.molmet.2023.101730
work_keys_str_mv AT chenlinshan interdisciplinaryadvancesreshapethedeliverytoolsforeffectivenashtreatment
AT wangyibing interdisciplinaryadvancesreshapethedeliverytoolsforeffectivenashtreatment